Welcome to LookChem.com Sign In|Join Free
  • or
N-Acetyl-5-Hydroxytryptamine, also known as N-Acetylserotonin (NAS) or normelatonin, is a metabolite of melatonin and a member of the class of hydroxyindoles. It is the N-acetyl derivative of serotonin and acts as a precursor of melatonin in the tryptophan metabolic pathway. N-Acetyl-5-Hydroxytryptamine is a white to off-white or slightly pink powder.

1210-83-9

Post Buying Request

1210-83-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1210-83-9 Usage

Uses

Used in Pharmaceutical Industry:
N-Acetyl-5-Hydroxytryptamine is used as an intermediate compound for the synthesis of melatonin, which is essential for regulating sleep-wake cycles and has various health benefits.
Used in Neuroscientific Research:
N-Acetyl-5-Hydroxytryptamine is used as a research tool to study the effects of N-ACETYL-5-HYDROXYTRYPTAMINE on neuron cells and its influence on Krüppel-like factor 15 (KLF15) expression, which can provide insights into the underlying mechanisms of various neurological conditions and potential therapeutic applications.
Used in Sleep Regulation:
N-Acetyl-5-Hydroxytryptamine is used as a precursor in the production of melatonin, which plays a crucial role in regulating the sleep-wake cycle and maintaining circadian rhythm. This application is particularly relevant in the development of sleep aids and treatments for sleep disorders.

Biological Activity

n-acetylserotonin is an agonist at the melatonin receptors mt1, mt2, and mt3.a melatonin receptor is a g protein-coupled receptor binding melatonin. three types of melatonin receptor have been identified. the mt1 and mt2 receptor subtypes are in humans and other mammals, whereas an additional melatonin receptor subtype mt3 has been identified in amphibia and birds.

Biochem/physiol Actions

N-acetyl-serotonin (NAS/normelatonin) can act as a shelter to neurons due to its protecting ability against oxidative challenges. It can also repress the actions of the transcription factor NF-kappaB. NAS possesses antioxidant and antiaging actions. It has protective action against β-amyloid induced neurotoxicity. It helps to maintain the optimal fluidity of the biological membranes.

in vitro

n-acetylserotonin, a precursor of melatonin, was acetylated from serotonin by arylalkylamine nacetyltransferase (aanat). n-acetylserotonin was found to be able to swiftly activate trkb in a circadian manner. n-acetylserotonin also exhibited antidepressant effect in a trkb-dependent manner. in additioin, n-acetylserotonin could rapidly activate trkb, but not trka or trkc, in a neurotrophin- and mt3 receptor-independent manner. moreover, n-acetylserotonin, but not melatonin, showed a robust antidepressant-like behavioral effect in a trkb-dependent way [1].

in vivo

animal study found that in bdnf knockout mice the administration of n-acetylserotonin could activate trkb. moreover, the endogenous trkb was activated in wild-type c3h/f+/+ mice but not in aanat-mutated c57bl/6j mice, in a circadian rhythm. in addition, trkb activation was found to be high at night in the dark and low during the day [1].

references

[1] jang, s. w.,liu, x.,pradoldej, s., et al. n-acetylserotonin activates trkb receptor in a circadian rhythm. proceedings of the national academy of sciences of the united states of america 107(8), 3876-3881 (2010).

Check Digit Verification of cas no

The CAS Registry Mumber 1210-83-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,2,1 and 0 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1210-83:
(6*1)+(5*2)+(4*1)+(3*0)+(2*8)+(1*3)=39
39 % 10 = 9
So 1210-83-9 is a valid CAS Registry Number.
InChI:InChI=1/C12H14N2O2/c1-8(15)13-5-4-9-7-14-12-3-2-10(16)6-11(9)12/h2-3,6-7,14,16H,4-5H2,1H3,(H,13,15)

1210-83-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name N-acetylserotonin

1.2 Other means of identification

Product number -
Other names N-Acetyl-5-hydroxytryptamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1210-83-9 SDS

1210-83-9Synthetic route

N-{2-[5-(benzyloxy)-1H-indol-3-yl]ethyl}acetamide
68062-88-4

N-{2-[5-(benzyloxy)-1H-indol-3-yl]ethyl}acetamide

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
With hydrogen; nickel In ethanol under 2068.6 Torr;95%
With palladium 10% on activated carbon; hydrogen; ammonium formate In ethanol for 2h; Reflux; Inert atmosphere;85%
With hydrogen; nickel
With palladium on activated charcoal; hydrogen In ethyl acetate
vinyl acetate
108-05-4

vinyl acetate

3-(2-aminoethyl)-1H-indol-5-ol
50-67-9

3-(2-aminoethyl)-1H-indol-5-ol

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
With agarose immobilized acetyltransferase from Mycobacterium smegmatis (MsAcT) In aq. phosphate buffer; dimethyl sulfoxide at 25℃; under 760.051 Torr; for 0.0833333h; pH=8.0; Flow reactor; Enzymatic reaction; chemoselective reaction;85%
NSC 73391
2436-15-9

NSC 73391

acetic anhydride
108-24-7

acetic anhydride

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In tetrahydrofuran at 50℃; under 3000.3 Torr; for 12h; Inert atmosphere;71%
3-(2-acetamidoethyl)-1H-indol-5-yl acetate
28026-16-6

3-(2-acetamidoethyl)-1H-indol-5-yl acetate

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
With potassium carbonate In methanol at 20℃; for 1.6h;65%
With potassium carbonate In methanol at 26℃; for 2h;
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
With boron tribromide In dichloromethane at -78 - 20℃;45%
Stage #1: 5-methoxy-N-acetyl-tryptamine With boron tribromide In dichloromethane at -78℃; for 1h;
Stage #2: With hydrogenchloride In dichloromethane; water at -78 - 20℃;
45%
Nb-acetyl-1-hydroxytriptamine
136788-90-4

Nb-acetyl-1-hydroxytriptamine

A

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

B

N,N'-diacetyl-2,2'-biindolyl-3,3'-bis(2-aminoethane)
176244-66-9

N,N'-diacetyl-2,2'-biindolyl-3,3'-bis(2-aminoethane)

C24H26N4O4

C24H26N4O4

Conditions
ConditionsYield
With trifluoroacetic acidA 13%
B 17%
C 33%
formic acid
64-18-6

formic acid

Nb-acetyl-1-hydroxytriptamine
136788-90-4

Nb-acetyl-1-hydroxytriptamine

A

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

B

Nb-acetyl-1-formyl-5-hydroxytryptamine

Nb-acetyl-1-formyl-5-hydroxytryptamine

Conditions
ConditionsYield
for 19h; Ambient temperature;A 17%
B 19%
3-(2-aminoethyl)-1H-indol-5-ol
50-67-9

3-(2-aminoethyl)-1H-indol-5-ol

acetyl chloride
75-36-5

acetyl chloride

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
In acetonitrile at 20℃; Acetylation;
serotonin creatinine sulfate
971-74-4

serotonin creatinine sulfate

[14C]acetyl-CoA

[14C]acetyl-CoA

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
With sheep pineal supernatant (serotonin-N-acetyl transferase); Pargyline In phosphate buffer at 37℃; for 0.166667h; pH=6.8; Enzyme kinetics;
5-benzyloxytryptamine
20776-45-8

5-benzyloxytryptamine

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 74 percent / aq. HCl, NaOAc / 1 h
2: 95 percent / H2 / Raney nickel / ethanol / 2068.6 Torr
View Scheme
Multi-step reaction with 2 steps
1: NaOAc
2: H2 / Raney Ni
View Scheme
Multi-step reaction with 2 steps
1: triethylamine / dichloromethane
2: palladium on activated charcoal; hydrogen / ethyl acetate
View Scheme
aluminum nickel

aluminum nickel

5-benzyloxytryptamine
20776-45-8

5-benzyloxytryptamine

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
With sodium acetate; acetic anhydride In hydrogenchloride; methanol; ethanol
3-(2-aminoethyl)-1H-indol-5-ol
50-67-9

3-(2-aminoethyl)-1H-indol-5-ol

A

O-diacetyl serotonine

O-diacetyl serotonine

B

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
With sodium hydroxide; acetic anhydride
3-(2-aminoethyl)-1H-indol-5-ol
50-67-9

3-(2-aminoethyl)-1H-indol-5-ol

acetylcoenzyme A
72-89-9

acetylcoenzyme A

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
With sea bream arylalkylamine N-acetyltransferase containing I157M mutation at β5 region Kinetics; Reagent/catalyst; Enzymatic reaction;
With 5,5'-dithiobis-(2-nitrobenzoic acid); Drosophila melanogaster arylalkylamine N-acetyltransferase A from E. coli In aq. buffer pH=8; Kinetics; Enzymatic reaction;
With dipyridin-4-yl disulfide; wild-type arylalkylamine N-acyltransferase from Tribolium castaneum In aq. buffer pH=8; Kinetics; Enzymatic reaction;
NSC 73391
2436-15-9

NSC 73391

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium tetrahydroborate; nickel(II) chloride hexahydrate / methanol / 20 h / 0 - 20 °C / Inert atmosphere
2: palladium 10% on activated carbon; hydrogen; ammonium formate / ethanol / 2 h / Reflux; Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1: lithium aluminium tetrahydride / diethyl ether / 0 °C
2: triethylamine / dichloromethane
3: palladium on activated charcoal; hydrogen / ethyl acetate
View Scheme
serotonin hydrochloride
153-98-0

serotonin hydrochloride

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine / dichloromethane / 5 h / 0 - 26 °C
2: potassium carbonate / methanol / 2 h / 26 °C
View Scheme
Multi-step reaction with 2 steps
1: triethylamine / dichloromethane / 14 h / 0 - 20 °C / Inert atmosphere
2: potassium carbonate / methanol / 1.6 h / 20 °C
View Scheme
N-acetylserotonine-O-sulfate

N-acetylserotonine-O-sulfate

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
With Helix pomatia arylsulfatase In aq. acetate buffer at 21℃; for 24h; Catalytic behavior; Enzymatic reaction;
With arylsulfatase from Helix pomatia In aq. acetate buffer at 21℃; for 24h; pH=7; Enzymatic reaction;
3-(2-aminoethyl)-1H-indol-5-ol
50-67-9

3-(2-aminoethyl)-1H-indol-5-ol

ethyl acetate
141-78-6

ethyl acetate

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
With agarose immobilized acetyltransferase from Mycobacterium smegmatis (MsAcT) In aq. phosphate buffer; dimethyl sulfoxide at 25℃; under 760.051 Torr; for 0.0833333h; pH=8.0; Flow reactor; Enzymatic reaction; chemoselective reaction;
3-(2-aminoethyl)-1H-indol-5-ol
50-67-9

3-(2-aminoethyl)-1H-indol-5-ol

arabidopsis serotonin N-acetyltransferase-2

arabidopsis serotonin N-acetyltransferase-2

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
With acetylcoenzyme A In aq. phosphate buffer at 45℃; for 1h; pH=7.8; Enzymatic reaction;
5-benzyloxy-1H-indole
1215-59-4

5-benzyloxy-1H-indole

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: acetic acid
2: N,N-dimethyl-formamide; water / 80 °C
3: lithium aluminium tetrahydride / diethyl ether / 0 °C
4: triethylamine / dichloromethane
5: palladium on activated charcoal; hydrogen / ethyl acetate
View Scheme
5-benzyloxygramine
1453-97-0

5-benzyloxygramine

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: N,N-dimethyl-formamide; water / 80 °C
2: lithium aluminium tetrahydride / diethyl ether / 0 °C
3: triethylamine / dichloromethane
4: palladium on activated charcoal; hydrogen / ethyl acetate
View Scheme
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Nb-acetyltryptamine-4,5-dione
172983-04-9

Nb-acetyltryptamine-4,5-dione

Conditions
ConditionsYield
With potassium nitrososulfonate In methanol; water at 0℃; for 0.5h;99%
With potassiuim nitrosodisulfonate In water for 3h;11 mg
(E)-3-(2-(trifluoromethyl)phenyl)acrylic acid
98386-81-3

(E)-3-(2-(trifluoromethyl)phenyl)acrylic acid

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

3-(2-acetamidoethyl)-1H-indol-5-yl (E)-3-(2-(trifluoromethyl)phenyl)acrylate

3-(2-acetamidoethyl)-1H-indol-5-yl (E)-3-(2-(trifluoromethyl)phenyl)acrylate

Conditions
ConditionsYield
With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 20℃; for 3.5h; Inert atmosphere;97%
(E)-3-(4-methoxyphenyl)acrylic acid
943-89-5

(E)-3-(4-methoxyphenyl)acrylic acid

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

3-(2-acetamidoethyl)-1H-indol-5-yl (E)-3-(4-methoxyphenyl)acrylate

3-(2-acetamidoethyl)-1H-indol-5-yl (E)-3-(4-methoxyphenyl)acrylate

Conditions
ConditionsYield
With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 20℃; for 1h; Inert atmosphere;96%
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

Nb-acetyl-1-methoxytryptamine
180910-62-7

Nb-acetyl-1-methoxytryptamine

Conditions
ConditionsYield
In methanol Ambient temperature;94%
trans-3-methoxycinnamic acid
6099-04-3

trans-3-methoxycinnamic acid

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

3-(2-acetamidoethyl)-1H-indol-5-yl (E)-3-(3-methoxyphenyl)acrylate

3-(2-acetamidoethyl)-1H-indol-5-yl (E)-3-(3-methoxyphenyl)acrylate

Conditions
ConditionsYield
With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 20℃; for 2h; Inert atmosphere;93%
(E)-but-2-enoic acid
107-93-7

(E)-but-2-enoic acid

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

3-(2-acetamidoethyl)-1H-indol-5-yl (E)-2-butenoate

3-(2-acetamidoethyl)-1H-indol-5-yl (E)-2-butenoate

Conditions
ConditionsYield
With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 20℃; for 1.5h; Inert atmosphere;76%
trans-p-methylcinnamic acid
1866-39-3

trans-p-methylcinnamic acid

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

3-(2-acetamidoethyl)-1H-indol-5-yl (E)-3-(4-methylphenyl)acrylate

3-(2-acetamidoethyl)-1H-indol-5-yl (E)-3-(4-methylphenyl)acrylate

Conditions
ConditionsYield
With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 20℃; for 2.5h; Inert atmosphere;75%
2-methoxycinnamic acid
1011-54-7

2-methoxycinnamic acid

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

3-(2-acetamidoethyl)-1H-indol-5-yl (E)-3-(2-methoxyphenyl)acrylate

3-(2-acetamidoethyl)-1H-indol-5-yl (E)-3-(2-methoxyphenyl)acrylate

Conditions
ConditionsYield
With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 20℃; for 3h; Inert atmosphere;71%
1-bromo-hexane
111-25-1

1-bromo-hexane

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

C18H26N2O2

C18H26N2O2

Conditions
ConditionsYield
With caesium carbonate In acetonitrile at 60℃; for 4h; Reflux; Inert atmosphere;68%
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

1-phenyl-2-bromoethane
103-63-9

1-phenyl-2-bromoethane

C20H22N2O2
1345995-63-2

C20H22N2O2

Conditions
ConditionsYield
With caesium carbonate In acetonitrile at 60℃; for 4h; Reflux; Inert atmosphere;65%
5-bromovaleric acid methyl ester
5454-83-1

5-bromovaleric acid methyl ester

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

5-[3-(2-acetylaminoethyl)-1H-indol-5-yloxy]pentanoic acid methyl ester

5-[3-(2-acetylaminoethyl)-1H-indol-5-yloxy]pentanoic acid methyl ester

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In acetonitrile Reflux; Inert atmosphere;63%
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

dimethyl sulfate
77-78-1

dimethyl sulfate

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With sodium hydroxide In water at 26℃; for 2.25h;61.4%
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

4-Nitrophenyl chloroformate
7693-46-1

4-Nitrophenyl chloroformate

3-[2-(acetylamino)ethyl]-1H-indol-5-yl 4-nitrophenyl carbonate
1415303-65-9

3-[2-(acetylamino)ethyl]-1H-indol-5-yl 4-nitrophenyl carbonate

Conditions
ConditionsYield
With 4-methyl-morpholine In tetrahydrofuran for 0.5h; Inert atmosphere;60%
With 4-methyl-morpholine
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

tert-butyl 6-bromohexylcarbamate
142356-33-0

tert-butyl 6-bromohexylcarbamate

tert-butyl N-(6-{[3-(2-acetamidoethyl)-1H-indol-5-yl]oxy}hexyl) carbamate

tert-butyl N-(6-{[3-(2-acetamidoethyl)-1H-indol-5-yl]oxy}hexyl) carbamate

Conditions
ConditionsYield
Stage #1: N-acetyl-5-hydroxytryptamine With potassium carbonate In acetonitrile for 1h; Reflux; Inert atmosphere;
Stage #2: tert-butyl 6-bromohexylcarbamate With sodium iodide In acetonitrile for 20h; Reflux; Inert atmosphere;
59%
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

ethyl isocyanate
109-90-0

ethyl isocyanate

carbamic acid 3-(2-acetylamino-ethyl)-1H-indol-5-yl ethyl ester
1269760-72-6

carbamic acid 3-(2-acetylamino-ethyl)-1H-indol-5-yl ethyl ester

Conditions
ConditionsYield
With sodium In tetrahydrofuran at 20℃; for 2h; Inert atmosphere;57%
3-(1-naphthyloxy)propyl bromide
3351-50-6

3-(1-naphthyloxy)propyl bromide

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

C25H26N2O3

C25H26N2O3

Conditions
ConditionsYield
With caesium carbonate In acetonitrile at 60℃; for 4h; Reflux; Inert atmosphere;57%
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

3-phenoxypropyl bromide
588-63-6

3-phenoxypropyl bromide

C21H24N2O3
1346011-09-3

C21H24N2O3

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In acetonitrile for 18h; Reflux; Inert atmosphere;56%
4-(3-bromopropoxy)-1,1′-biphenyl
113795-28-1

4-(3-bromopropoxy)-1,1′-biphenyl

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

C27H28N2O3

C27H28N2O3

Conditions
ConditionsYield
With caesium carbonate In acetonitrile at 60℃; for 4h; Reflux; Inert atmosphere;55%
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

phenoxyethyl bromide
589-10-6

phenoxyethyl bromide

C20H22N2O3
1346011-08-2

C20H22N2O3

Conditions
ConditionsYield
With caesium carbonate In acetonitrile at 60℃; for 4h; Reflux; Inert atmosphere;55%
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

allyl bromide
106-95-6

allyl bromide

C15H18N2O2
1345995-61-0

C15H18N2O2

Conditions
ConditionsYield
With caesium carbonate In acetonitrile at 60℃; for 4h; Reflux; Inert atmosphere;53%
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

C21H24N2O2
1345995-64-3

C21H24N2O2

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In acetonitrile for 18h; Reflux; Inert atmosphere;50%
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

2-bromomethylnaphthyl bromide
939-26-4

2-bromomethylnaphthyl bromide

N-{2-[5-(naphthalen-2-ylmethoxy)-1H-indol-3-yl]ethyl}-acetamide
1345995-62-1

N-{2-[5-(naphthalen-2-ylmethoxy)-1H-indol-3-yl]ethyl}-acetamide

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In acetonitrile for 18h; Reflux; Inert atmosphere;47%
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

8-amino>octyl bromide
142356-35-2

8-amino>octyl bromide

tert-butyl N-(8-{[3-(2-acetamidoethyl)-1H-indol-5-yl]oxy}octyl) carbamate

tert-butyl N-(8-{[3-(2-acetamidoethyl)-1H-indol-5-yl]oxy}octyl) carbamate

Conditions
ConditionsYield
Stage #1: N-acetyl-5-hydroxytryptamine With potassium carbonate In acetonitrile for 1h; Reflux; Inert atmosphere;
Stage #2: 8-amino>octyl bromide With sodium iodide In acetonitrile for 20h; Reflux; Inert atmosphere;
47%
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

1,3-dibromo-propane
109-64-8

1,3-dibromo-propane

C15H19BrN2O2

C15H19BrN2O2

Conditions
ConditionsYield
Stage #1: N-acetyl-5-hydroxytryptamine With sodium hydride In ethanol for 0.5h;
Stage #2: 1,3-dibromo-propane In ethanol at 60℃; for 3h; Inert atmosphere;
46%
2-(3-bromopropoxy)naphthalene
3245-62-3

2-(3-bromopropoxy)naphthalene

N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

C25H26N2O3

C25H26N2O3

Conditions
ConditionsYield
With caesium carbonate In acetonitrile at 60℃; for 4h; Reflux; Inert atmosphere;43%

1210-83-9Relevant academic research and scientific papers

Knockout of arabidopsis serotonin N-acetyltransferase-2 reduces melatonin levels and delays flowering

Lee, Hyoung Yool,Lee, Kyungjin,Back, Kyoungwhan

, (2019)

Melatonin plays roles in both plant growth and defense. Serotonin N-acetyltransferase (SNAT) catalyzes formation of N-acetylserotonin (NAS) from serotonin. Plants contain two SNAT isogenes, which exhibit low-level amino acid homology. We studied the Arabidopsis thaliana SNAT2 (AtSNAT2) gene; we prepared recombinant SNAT2 protein and characterized a snat2 knockout mutant. The SNAT2 protein exhibited 27% amino acid homology with SNAT1; the Km was 232 μM and the Vmax was 2160 pmol/min/mg protein. Melatonin inhibited SNAT enzyme activity in vitro. SNAT2 mRNA was abundantly expressed in flowers; the melatonin content of flowers of the snat2 mutant was significantly less than that of wild-type flowers. The mutant exhibited delayed flowering and reductions in leaf area and biomass compared to the wild type. Delayed flowering was attributable to reductions in the expression levels of the gibberellin biosynthetic genes ent-kaurene synthase (KS) and FLOWERING LOCUS T (FT).

Synthesis and evaluation of the antiovulatory activity of a variety of melatonin analogues

Flaugh,Crowell,Clemens,Sawyer

, p. 63 - 69 (1979)

A series of melatonin analogues was synthesized and examined for ovulation-blocking activity. Deviation from the 5-methoxy group or substitution of the 1 position prevented activity. Activity was not particularly sensitive to minor variations in the N-acyl group nor was it significantly altered by methylation of position 2 or the α-methylene; however, a pronounced enhancement resulted from halogenation of the 6 position.

Mutasynthesis of Physostigmines in Myxococcus xanthus

Winand, Lea,Schneider, Pascal,Kruth, Sebastian,Greven, Nico-Joel,Hiller, Wolf,Kaiser, Marcel,Pietruszka, J?rg,Nett, Markus

, p. 6563 - 6567 (2021)

The alkaloid physostigmine is an approved anticholinergic drug and an important lead structure for the development of novel therapeutics. Using a complementary approach that merged chemical synthesis with pathway refactoring, we produced a series of physostigmine analogues with altered specificity and toxicity profiles in the heterologous host Myxococcus xanthus. The compounds that were generated by applying a simple feeding strategy include the promising drug candidate phenserine, which was previously accessible only by total synthesis.

Synthesis process of melatonin intermediate N-acetyl serotonin

-

Paragraph 0026-0041, (2021/09/15)

The invention relates to the technical field of biological semi-synthesis, and provides a synthesis process of a melatonin intermediate N-acetyl serotonin, wherein the synthesis process comprises the following steps: S1, adding serotonin hydrochloride into dichloromethane, and stirring; S2, adding triethylamine and sodium bicarbonate, stirring into a suspension, and cooling in the process; S3, adding an acetylation reagent; S4, heating and stirring the reaction mixture; and S5, after the reaction is finished, carrying out post-treatment. According to the technical scheme, the problems that in the prior art, the technological process is complex, and the product quality is poor are solved.

BIOMARKER PANEL TARGETED TO DISEASES DUE TO MULTIFACTORIAL ONTOLOGY OF GLYCOCALYX DISRUPTION

-

, (2021/04/02)

The present disclosure provides biomarkers useful as companion diagnostics for detecting glycocalyx-based disease that is amenable to treatment using compounds designed for improving the condition of the glycocalyx and/or reducing inflammation and/or oxidative damage, as well as related compositions, kits, and methods.

Biocatalytic C3-Indole Methylation—A Useful Tool for the Natural-Product-Inspired Stereoselective Synthesis of Pyrroloindoles

Schneider, Pascal,Hen?en, Birgit,Paschold, Beatrix,Chapple, Benjamin P.,Schatton, Marcel,Seebeck, Florian P.,Classen, Thomas,Pietruszka, J?rg

, p. 23412 - 23418 (2021/09/20)

Enantioselective synthesis of bioactive compounds bearing a pyrroloindole framework is often laborious. In contrast, there are several S-adenosyl methionine (SAM)-dependent methyl transferases known for stereo- and regioselective methylation at the C3 position of various indoles, directly leading to the formation of the desired pyrroloindole moiety. Herein, the SAM-dependent methyl transferase PsmD from Streptomyces griseofuscus, a key enzyme in the biosynthesis of physostigmine, is characterized in detail. The biochemical properties of PsmD and its substrate scope were demonstrated. Preparative scale enzymatic methylation including SAM regeneration was achieved for three selected substrates after a design-of-experiment optimization.

Characterization of arylalkylamine n-acyltransferase from tribolium castaneum: an investigation into a potential next-generation insecticide target

Anderson, Ryan L.,Chen, Yu,Gelis, Ioannis,Leahy, James W.,Lewandowski, Eric M.,Mccaskey, Angelica N.,Merkler, David J.,O'flynn, Brian G.,Prins, Karin Claire,Rios-Guzman, Nasha M.,Shepherd, Britney A.,Suarez, Gabriela

, p. 513 - 523 (2020/03/11)

The growing issue of insecticide resistance has meant the identification of novel insecticide targets has never been more important. Arylalkylamine N-acyltransferases (AANATs) have been suggested as a potential new target. These promiscuous enzymes are involved in the N-acylation of biogenic amines to form N-acylamides. In insects, this process is a key step in melanism, hardening of the cuticle, removal of biogenic amines, and in the biosynthesis of fatty acid amides. The unique nature of each AANAT isoform characterized indicates each organism accommodates an assembly of discrete AANATs relatively exclusive to that organism. This implies a high potential for selectivity in insecticide design, while also maintaining polypharmacology. Presented here is a thorough kinetic and structural analysis of AANAT found in one of the most common secondary pests of all plant commodities in the world, Tribolium castaneum. The enzyme, named TcAANAT0, catalyzes the formation of short-chain N-acylarylalkylamines, with short-chain acyl-CoAs (C2-C10), benzoyl-CoA, and succinyl-CoA functioning in the role of acyl donor. Recombinant TcAANAT0 was expressed and purified from E. coli and was used to investigate the kinetic and chemical mechanism of catalysis. The kinetic mechanism is an ordered sequential mechanism with the acyl-CoA binding first. pH-rate profiles and site-directed mutagenesis studies identified amino acids critical to catalysis, providing insights about the chemical mechanism of TcAANAT0. A crystal structure was obtained for TcAANAT0 bound to acetyl-CoA, revealing valuable information about its active site. This combination of kinetic analysis and crystallography alongside mutagenesis and sequence analysis shines light on some approaches possible for targeting TcAANAT0 and other AANATs for novel insecticide design.

Flow-based enzymatic synthesis of melatonin and other high value tryptamine derivatives: A five-minute intensified process

Contente, Martina Letizia,Farris, Stefano,Tamborini, Lucia,Molinari, Francesco,Paradisi, Francesca

supporting information, p. 3263 - 3266 (2019/06/24)

To increase the uptake of biocatalytic processes by industry, it is essential to demonstrate the reliability of enzyme-based methodologies directly applied to the production of high value products. Here, a unique, efficient, and sustainable enzymatic platform for the multi-gram synthesis of melatonin, projected to generate around 1.5 billion U.S. dollars worldwide by 2021, and its analogues was developed. The system exploits the covalent immobilization of MsAcT (transferase from Mycobacterium smegmatis) onto agarose beads increasing the robustness and longevity of the immobilized biocatalyst. The fully-automated process deriving from the integration between biocatalysis and flow chemistry is designed to maximize the overall yields (58-92%) and reduce reaction times (5 min), overcoming the limitation often associated with bioprocesses and bridging the gap between lab scale and industrial production.

Comprehensive kinetic and substrate specificity analysis of an arylsulfatase from Helix pomatia using mass spectrometry

Correia, Mário S.P.,Ballet, Caroline,Meistermann, Hannes,Conway, Louis P.,Globisch, Daniel

, p. 955 - 962 (2019/02/09)

Sulfatases hydrolyze sulfated metabolites to their corresponding alcohols and are present in all domains of life. These enzymes have found major application in metabolic investigation of drugs, doping control analysis and recently in metabolomics. Interest in sulfatases has increased due to a link between metabolic processes involving sulfated metabolites and pathophysiological conditions in humans. Herein, we present the first comprehensive substrate specificity and kinetic analysis of the most commonly used arylsulfatase extracted from the snail Helix pomatia. In the past, this enzyme has been used in the form of a crude mixture of enzymes, however, recently we have purified this sulfatase for a new application in metabolomics-driven discovery of sulfated metabolites. To evaluate the substrate specificity of this promiscuous sulfatase, we have synthesized a series of new sulfated metabolites of diverse structure and employed a mass spectrometric assay for kinetic substrate hydrolysis evaluation. Our analysis of the purified enzyme revealed that the sulfatase has a strong preference for metabolites with a bi- or tricyclic aromatic scaffold and to a lesser extent for monocyclic aromatic phenols. This metabolite library and mass spectrometric method can be applied for the characterization of other sulfatases from humans and gut microbiota to investigate their involvement in disease development.

New enzymatic and mass spectrometric methodology for the selective investigation of gut microbiota-derived metabolites

Ballet, Caroline,Correia, Mário S. P.,Conway, Louis P.,Locher, Theresa L.,Lehmann, Laura C.,Garg, Neeraj,Vujasinovic, Miroslav,Deindl, Sebastian,L?hr, J.-Matthias,Globisch, Daniel

, p. 6233 - 6239 (2018/08/07)

Gut microbiota significantly impact human physiology through metabolic interaction. Selective investigation of the co-metabolism of bacteria and their human host is a challenging task and methods for their analysis are limited. One class of metabolites associated with this co-metabolism are O-sulfated compounds. Herein, we describe the development of a new enzymatic assay for the selective mass spectrometric investigation of this phase II modification class. Analysis of human urine and fecal samples resulted in the detection of 206 sulfated metabolites, which is three times more than reported in the Human Metabolome Database. We confirmed the chemical structure of 36 sulfated metabolites including unknown and commonly reported microbiota-derived sulfated metabolites using synthesized internal standards and mass spectrometric fragmentation experiments. Our findings demonstrate that enzymatic sample pre-treatment combined with state-of-the-art metabolomics analysis represents a new and efficient strategy for the discovery of unknown microbiota-derived metabolites in human samples. Our described approach can be adapted for the targeted investigation of other metabolite classes as well as the discovery of biomarkers for diseases affected by microbiota.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1210-83-9